Cancer vaccines
C96 – C100
- C96: An MVA based vaccine targeting the oncofoetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases
- C97: Vaccination of patients with Epstein-Barr virus (EBV) positive malignancy with modified Vaccinia Ankara expressing a chimaeric EBV EBNA 1 and LMP2 antigen
- C98: Immunotherapy for head and neck carcinoma by transimmunization
- C99: Phase 2 trials of sequential imiquimod followed by photodynamic therapy or therapeutic HPV vaccine for high grade vulval intraepithelial neoplasia
- C100: Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study
